Publications

  1. Rosendaal FR, Smit C, Briet E. Hemophilia treatment in historical perspective: a review of medical and social developments. Ann.Hematol. 1991;62(1):5-15.
  2. Zwart-van Rijkom JE, Plug I, Rosendaal FR, Leufkens HG, Broekmans AW. The uptake of recombinant Factor VIII in the Netherlands. Br.J.Haematol. 2002;119(2):332-41.
  3. Plug I, Van der Bom JG, Peters M, Mauser-Bunschoten EP, Goede-Bolder A, Heijnen L et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. Journal of Thrombosis and Haemostasis 2006; 4(3):510-516.
  4. Plug I, Mauser-Bunschoten E.P, Bröcker-Vriends A.H.J.T, Bom van der J.G, van Diemen J.E.M, Ploos van Amstel J.K, Rosendaal F.R. Bleeding in carriers of hemophilia. Blood 2006 Jul 1;108(1):52-6.
  5. Plug I, van der Bom J.G, Peters M, Mauser-Bunschoten E.P, de Goede Bolder A, Heijnen L, Smit C, Zwart-van Rijkom J.E.F, Willemse J, Rosendaal F.R. Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood 2004 Dec 1;104(12):3494-500.
  6. Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP. Hepatitis C infection among Dutch hemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia 2005; 11: 270-275.
  7. Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP. Hepatitis C and health-related quality of life among patients with hemophilia. Haematologica 2005; 90: 846-850.